icon-    folder.gif   Conference Reports for NATAP  
 
  IAS 2015: 8th IAS Conference on
HIV Pathogenesis Treatment and Prevention
Vancouver, Canada
18-22 July 2015
Back grey_arrow_rt.gif
 
 
 
Safety and Efficacy of DTG by Age, Race and Gender: Subgroup Analysis of 96 Week Results From Treatment-Naive Patients in Phase III Trials (SPRING-2 [ING113086], SINGLE [ING114467] and FLAMINGO [ING114915])
 
 
  Reported by Jules Levin
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2015; Vancouver, Canada
 
Koteff,1 R Cuffe,2 C Granier,3 A Zolopa,1 A Murungi,2 B Wynne,4 M Aboud,2 K Smith1 1ViiV Healthcare, Research Triangle Park, NC, USA; 2ViiV Healthcare, Middlesex, United Kingdom; 3GlaxoSmithKline, London, United Kingdom; 4GlaxoSmithKline, Research Triangle Park, NC, USA

IAS1.gif

IAS2.gif

IAS3.gif

IAS5.gif

IAS6.gif

IAS7.gif

IAS8.gif